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Abstract: Aim: The aim of this study was to compare the estimation of ejection fraction (EF) by ventricuography (VG) 
and echocardiography (ECHO) in patients referred for surgery and to validate the results by comparison with other 
published data. 
Methods: One hundred patients who underwent VG prior to surgery were subjected to a trans-thoracic ECHO. 
Radiographers calculated the EF by tracing the outer border of the ventriculogram during systole and diastole. A single 
cardiologist, who was blinded to the angiogram result, measured EF during trans-thoracic ECHO using the biplane 
Simpson’s method.  
Results: EF was significantly higher by VG versus ECHO for the whole group (67.9±13.2 vs 55.7±8.5, p=0.000). In 81 
patients the EF estimated at VG was higher than that calculated at ECHO (71.7±10.2 vs 55.9±7.2, p=0.000). In 19 
patients the EF estimated at VG was lower than that calculated at ECHO, but the difference was not significant 
(51.8±12.9 by VG vs 55.4±12.8, p=0.387). In 13 patients, with an EF less than 50% on VG, the correlation with ECHO 
was very good (42.0±9.0 vs 42.0±8.3, p=0.995). Two patients with an EF fraction under 30% had similar measurements 
by VG and ECHO. The EF range as measured by ECHO was consistent with published data. 
Conclusion: Ventriculography overestimates EF when compared with ECHO. When EF is less than 50% on VG, ECHO 
findings were similar. The value of ventriculography in patients referred for cardiac surgery is now being brought into 
question when ECHO, a better and less invasive test that measures EF, is available.  
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INTRODUCTION 
Ejection fraction is readily measured invasively at 
ventriculography and non-invasively by echocardio-
graphy. A value of around 65% is considered normal 
[1]. Ejection fraction contributes to pre-operative risk 
assessment when using the Parsonnet or EuroSCORE 
systems. 
The calculation of EF and assessment of regional 
wall motion by contrast injection of the left ventricle has 
been a gold standard for over four decades [2] since its 
introduction by Seldinger in 1953 [3]. The increasing 
use of VG sparked concerns over radiation exposure 
[4] and brought its validity into question, especially 
when patients had already undergone echocardio-
graphic estimation of ventricular function [5,6]. Surveys 
have highlighted a wide divergence of its use, with the 
suggestion that reimbursement by private health 
schemes may be a driving force [7]. 
This is not an issue in our local public-funded Health 
Service. Although our resident surgeons, comfortable  
 
 
*Address corresponding to this author at the Department of Cardiothoracic 
Surgery, Mater Dei Hospital, Malta; Tel/Fax: +356 25455486;  
Mob: +356 79320111; E-mail: manchea@maltanet.net 
with ventriculography, initially expressed reluctance to 
embrace echocardiography, the strong drive to change 
eventually arose both from within our surgical fraternity 
as well as from cardiologists. 
Factors included the divergence of EF estimation 
between that calculated by radiographers and that 
visually estimated by surgeons, the elevated range of 
EF calculated locally by ventriculography, far excee-
ding internationally expected norms [8,9] resulting in an 
underestimation of operative risk, the increasing 
appointment of non-invasive cardiologists providing an 
ECHO service, and the increasing reluctance of 
invasive cardiologists to perform ventriculography.  
Against this background we evaluated our changing 
practice in order to define the place of invasive versus 
non-invasive EF estimation in patients referred for 
surgery. 
METHODS 
One hundred patients who were referred for a 
cardiac surgical procedure and had undergone VG 
were subjected to a trans-thoracic ECHO. The history 
excluded an interval episode and the ECHO was 
performed soon after the VG.  
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Patients who were considered possible candidates 
for surgery were first screened in order to ascertain the 
need for invasive investigation. Ventriculography was 
always performed as part of the coronary angiogram 
and invasive pressure measurements. The 
interventional cardiologist established that the patient 
had reached a steady cardiovascular state before 
injecting contrast. Radiographers traced the outer 
border of the ventriculogram during systole and 
diastole (two dimensional area), and entered this data 
to compute the ejection fraction by standard methods 
using derived systolic and diastolic volumes [10].  
A single cardiologist, blinded to the VG results, 
estimated the EF on trans-thoracic ECHO, using the 
biplane Simpson’s method [11]. Other parameters 
relating to valvular function, regional wall motion and 
areas of interest relevant to the patient’s specific heart 
disease were recorded during this echocardiogram. 
Measurements were taken when the patients reached 
a steady state at rest.  
Ejection fraction was expressed as a percentage of 
stroke volume divided by end-diastolic volume.  
Means and standard deviations were used to 
measure central tendency and dispersion for 
continuous variables and the unpaired t-test was used 
to compare mean EF calculated by VG and ECHO 
modalities, given that both variables satisfied the 
normality assumption. A 0.05 level of significance was 
adopted in all comparisons.  
RESULTS 
Seventy-three patients were male and mean age for 
the whole group was 65.7±9.6 years (males 63.5±9.6, 
females 71.4±7.1). All patients underwent surgery with 
the following procedures: 55 coronary artery bypass 
grafting, 12 aortic valve replacement, 10 aortic valve 
replacement with concomitant grafting, 10 mitral valve 
repair, 8 mitral valve replacement and 5 other 
miscellaneous procedures. The time interval between 
the two tests was 25.8±20.8 days. The absence of any 
intervening episode from the measurement of VG was 
ascertained at the time of ECHO. 
EF was significantly higher by VG versus ECHO for 
the whole group (67.9±13.2 vs 55.7±8.5, p=0.000) 
Figure 1.  
In 81 patients the EF estimated at VG was higher 
than that calculated at ECHO (71.7±10.2 vs 55.9±7.2, 
p=0.000). In 19 patients the EF estimated at VG was 
lower than that calculated at ECHO, but the difference 
was not significant (51.8±12.9 by VG vs 55.4±12.8, 
p=0.387) Figure 2.  
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Figure 1: Black lines EF by VG > EF by ECHO. Red lines EF 
by VG < EF by ECHO. 
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Figure 2: Red lines EF by VG < EF by ECHO. 
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In patients with an EF less than 50% on VG (n=13), 
ECHO estimations were similar (42.0±9.0 vs 42.0±8.3, 
p=0.995) Figure 3.  
50
60
70
80
90
40
50
60
70
80
90
40
30 30
20 20
ECHOVG
p=0.995
 
Figure 3: EF by VG < 50%, red lines EF by VG < EF by 
ECHO. 
Two patients with an EF fraction under 30% had 
similar measurements by VG and ECHO. 
 
Figure 4: Percentage distribution of EF: poor < 30%, fair 30-
50%, good >50%. 
The range of EF was compared with internationally 
published data, both from Europe and from China 
(Figure 4) [8,9].  
The proportion of local patients deemed to have a 
poor or fair left ventricular function as measured by VG 
during the period 2001-2012 was much lower than in 
other contemporaneous series (Malta 2001-2012, UK 
2001-2008, China 2006-2008). 
DISCUSSION 
The trend internationally is for an increase in non-
invasive at the cost of invasive investigation. This 
applies both for the assessment of EF [12] as well as 
for estimation of the significance of coronary lesions in 
ischaemia [13,14]. Ejection fraction is not the sole test 
for evaluating heart function, and diastolic dysfunction, 
easily assessed by ECHO, is gaining increasing 
importance [15].  
Several technical pitfalls may affect EF estimation 
on VG. The formula constant may require calibration in 
relation to other methods of measurement, such as 
ECHO or radionuclide ventriculography. Inaccurate 
tracing of the ventricular cavity and filling defects 
caused by papillary muscles, especially with left 
ventricular hypertrophy may underestimate end-systolic 
volume. A high position of the catheter within the 
ventricle, or inadequate contrast volume and rate of 
injection, especially with smaller catheters, both fail to 
delineate the entire cavity adequately. Measurements 
taken during ventricular ectopics or salvos, caused by 
the catheter or the injection, or after a compensatory 
pause, are not representative because of the influence 
on ventricular filling. A left ventricular aneurysm may 
not be adequately filled, underestimating the true 
dimensions. Similarly, poor windows or indefinite 
endocardial border definition may hinder ECHO 
measurements. Ventricular aneurysm invalidates EF 
estimation using formulae based on a normal 
ventricular contour [16]. Finally there may be variations 
in the way different cardiologists perform the 
ventriculogram and also in the delineation of ventricular 
contours by various radiographers. 
The EF range as measured locally by VG was 
vastly higher than other published data [9]. These 
ranges were for patients referred for cardiac surgery 
contemporaneously (Malta n=1649, 2001-2012, 
Harefield n=4408, Papworth n=8862, 2001-2008, China 
n=8774, 2006-2008). Our local EF for this specified 
cohort was 71.8±13.6 versus a normally quoted range 
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of 62.3±6.1 [17]. Overestimation of EF by VG has been 
described previously [18].  
Ejection fraction affects predicted outcome in widely 
used surgical risk-stratification systems, with 
increments at EF <50% and <30% [19-21]. Eleven 
patients in our study, with an EF >50% by VG would 
have been reclassified as <50% by ECHO, with a 
consequent increase in risk-stratification score (Figure 
5).  
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Figure 5: EF > 50% by VG and < 50% by ECHO. 
Figure 6 shows the local trend for the use of ECHO 
for EF estimation over time. 
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Figure 6: Use of ECHO for EF estimation over time. 
LIMITATIONS 
Ejection fraction is one of many contributory factors 
in the estimation of operative risk and outcome. The 
emergence of newer risk stratification systems 
designed to deal with a changing surgical population 
makes the correlation between EF and outcomes 
difficult to accurately quantify. This study did not 
address outcomes in terms of EF by VG or ECHO. 
Locally acquired VG estimates were higher when 
compared with those reported in other registries, and 
hence the applicability or interpretation of these 
findings may be limited. 
CONCLUSION 
The pursuit of a gold standard in EF estimation is a 
concept largely subordinated by the local availability of 
techniques and practices. Each modality possesses its 
strengths and weaknesses and should be tailored to 
clinical need when patients are referred for surgery. 
Ventriculography overestimates EF when compared 
with ECHO and surgeons are cognizant of this 
shortcoming. When EF is less than 50% on VG, 
estimation by ECHO is similar. The value of 
ventriculography in patients referred for cardiac surgery 
is now being brought into question when ECHO, a 
better and less invasive test that measures EF, is 
available. The trend from VG to ECHO in our unit 
reflects these complex dynamics and has emerged for 
an increased use of ECHO as the sole method of EF 
estimation in patients referred for surgery. It behooves 
the surgeon to become increasingly acquainted with 
this modality as VG becomes less accessible. 
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